Potential association of thyrotoxicosis with vitamin B and folate deficiencies, resulting in risk for hyperhomocysteinemia and subsequent thromboembolic events

Endocrine Practice

Volumn 9, Issue 4, 2003, Pages 290-295

  Colleran, Kathleen M ^a   Ratliff, Devona M ^a   Burge, Mark R ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLMALONIC ACID; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD CLOTTING; CASE REPORT; CLINICAL TRIAL; FEMALE; FOLIC ACID DEFICIENCY; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MIDDLE AGED; RISK FACTOR; THROMBOEMBOLISM; THYROTOXICOSIS; URINE; VITAMIN DEFICIENCY;

ADOLESCENT; ADULT; BLOOD COAGULATION; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; GRAVES DISEASE; HOMOCYSTEINE; HUMANS; HYPERTHYROIDISM; METHYLMALONIC ACID; MIDDLE AGED; RISK FACTORS; THROMBOEMBOLISM; THYROTOXICOSIS; THYROXINE; VITAMIN B 12; VITAMIN B DEFICIENCY;

EID: 2142803652     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.9.4.290     Document Type: Article

References (16)

1. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr. 1992;55:131-138.
2. Moghadasian MH, McManus BM, Frohlich JJ. Homocyst(e)ine and coronary artery disease: clinical evidence and genetic and metabolic background [erratum in Arch Intern Med. 1998;158:662]. Arch Intern Med. 1997;157:2299-2308.
3. Fallest-Strobl PC, Koch DD, Stein JH, Mcbride PE. Homocysteine: a new risk factor for atherosclerosis. Am Fam Physician. 1997;56:1607-1612.
4. Catargi B, Parrot-Roulaud F, Cochet C, Ducassou D, Roger P, Tabarin A. Homocysteine, hypothyroidism, and effect of thyroid hormone replacement. Thyroid. 1999;9:1163-1166.
5. Lien EA, Nedrebo BG, Varhaug JE, Nygard O, Aakvaag A, Ueland PM. Plasma total homocysteine levels during short-term iatrogenic hypothyroidism. J Clin Endocrinol Metab. 2000;85:1049-1053.
6. Hussein WI, Green R, Jacobsen DW, Faiman C. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Ann Intern Med. 1999;131:348-351.
7. Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersinga WM. Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol (Oxf). 2001;54:197-204.
8. Ingenbleek Y, Barclay D, Dirren H. Nutritional significance of alteration in serum amino acid patterns in goitrous patients. Am J Clin Nutr. 1986;43:310-319.
9. Jacobs RL, Stead LM, Brosnan ME, Brosnan JT. Plasma homocysteine is decreased in the hypothyroid rat. Can J Physiol Pharmacol. 2000;78:565-570.
10. Batra KK, Watson JE, Stokstad EL. Effect of dietary thyroid powder on urinary excretion of formiminoglutamic acid and methylmalonic acid. Proc Soc Exp Biol Med. 1979;161:589-593.
11. Chan MM, Stokstad EL. Metabolic responses of folic acid and related compounds to thyroxine in rats. Biochim Biophys Acta. 1980;632:244-253.
12. Nair CP, Viswanathan G, Noronha JM. Folate-mediated incorporation of ring-2-carbon of histidine into nucleic acids: influence of thyroid hormone. Metabolism. 1994; 43:1575-1578.
13. Keating JN, Kusano G, Stokstad EL. Effect of thiouracil in modifying folate function in severe vitamin B12 deficiency. Arch Biochem Biophys. 1998;257:119-124.
14. Stokstad EL, Nair CP. Effect of hypothyroidism on methylmalonate excretion and hepatic B-12 levels in rats. J Nutr. 1988;118:1495-1501.
15. Stabler SP, Lindenbaum J, Allen RH. The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency. J Nutr. 1996;126(4 Suppl): 1266S-1272S.
16. Koehler KM, Romero LJ, Stauber PM, et al. Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr. 1996;15:364-376.